Literature DB >> 18347598

A loss-of-function mutation in tryptophan hydroxylase 2 segregating with attention-deficit/hyperactivity disorder.

J McKinney, S Johansson, A Halmøy, M Dramsdahl, I Winge, P M Knappskog, J Haavik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18347598     DOI： 10.1038/sj.mp.4002152

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  15 in total

Review 1.  Advances in tryptophan hydroxylase-2 gene expression regulation: new insights into serotonin-stress interaction and clinical implications.

Authors:  Guo-Lin Chen; Gregory M Miller
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-03       Impact factor: 3.568

Review 2.  The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse.

Authors:  Jacob P R Jacobsen; Ivan O Medvedev; Marc G Caron
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

Review 3.  Targeting brain serotonin synthesis: insights into neurodevelopmental disorders with long-term outcomes related to negative emotionality, aggression and antisocial behaviour.

Authors:  Klaus-Peter Lesch; Naozumi Araragi; Jonas Waider; Daniel van den Hove; Lise Gutknecht
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

Review 4.  Serotonin gene variants are unlikely to play a significant role in the pathogenesis of the sudden infant death syndrome.

Authors:  David S Paterson
Journal:  Respir Physiol Neurobiol       Date:  2013-07-10       Impact factor: 1.931

5.  An Ultraconserved Brain-Specific Enhancer Within ADGRL3 (LPHN3) Underpins Attention-Deficit/Hyperactivity Disorder Susceptibility.

Authors:  Ariel F Martinez; Yu Abe; Sungkook Hong; Kevin Molyneux; David Yarnell; Heiko Löhr; Wolfgang Driever; Maria T Acosta; Mauricio Arcos-Burgos; Maximilian Muenke
Journal:  Biol Psychiatry       Date:  2016-07-14       Impact factor: 13.382

6.  Alternative splicing and extensive RNA editing of human TPH2 transcripts.

Authors:  Maik Grohmann; Paul Hammer; Maria Walther; Nils Paulmann; Andreas Büttner; Wolfgang Eisenmenger; Thomas C Baghai; Cornelius Schüle; Rainer Rupprecht; Michael Bader; Brigitta Bondy; Peter Zill; Josef Priller; Diego J Walther
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

7.  Melatonin and dopamine as biomarkers to optimize treatment in phenylketonuria: effects of tryptophan and tyrosine supplementation.

Authors:  Shoji Yano; Kathryn Moseley; Colleen Azen
Journal:  J Pediatr       Date:  2014-05-22       Impact factor: 4.406

8.  REVERSE phenotyping-Can the phenotype following constitutive Tph2 gene inactivation in mice be transferred to children and adolescents with and without adhd?

Authors:  Atae Akhrif; Arunima Roy; Katharina Peters; Klaus-Peter Lesch; Marcel Romanos; Angelika Schmitt-Böhrer; Susanne Neufang
Journal:  Brain Behav       Date:  2021-02-01       Impact factor: 2.708

Review 9.  The genetics of attention deficit/hyperactivity disorder in adults, a review.

Authors:  B Franke; S V Faraone; P Asherson; J Buitelaar; C H D Bau; J A Ramos-Quiroga; E Mick; E H Grevet; S Johansson; J Haavik; K-P Lesch; B Cormand; A Reif
Journal:  Mol Psychiatry       Date:  2011-11-22       Impact factor: 15.992

10.  A functional alternative splicing mutation in human tryptophan hydroxylase-2.

Authors:  X Zhang; P J Nicholls; G Laje; T D Sotnikova; R R Gainetdinov; P R Albert; G Rajkowska; C A Stockmeier; M C Speer; D C Steffens; M C Austin; F J McMahon; K R R Krishnan; M A Garcia-Blanco; M G Caron
Journal:  Mol Psychiatry       Date:  2010-09-21       Impact factor: 15.992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.